News
2d
Pharmaceutical Technology on MSNGilead wins positive European approval opinion for twice-yearly HIV injection
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...
The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.
The drug failed to meet its primary endpoints in clinical trials, but subgroup analyses hinted at modest benefits.
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
MetrioPharm’s lead compound, MP1032, has received ODD from the European Medicines Agency (EMA) for treating DMD in children.
4d
DPA International on MSNEMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
The EU's medicines regulator said it would approve the treatment for a limited group of patients, citing concerns over side effects ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
Sarepta Therapeutics failed to win the European drug regulator's backing for its muscle disorder gene therapy on Friday, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results